Breaking News Instant updates and real-time market news.

MNK

Mallinckrodt

$27.25

0.625 (2.35%)

06:03
11/06/18
11/06
06:03
11/06/18
06:03

Mallinckrodt raises FY18 adj. EPS view to $7.00-$7.20 from $6.50-$6.90

Consensus $6.75.

  • 06

    Nov

  • 14

    Nov

  • 16

    Nov

MNK Mallinckrodt
$27.25

0.625 (2.35%)

10/03/18
BMOC
10/03/18
NO CHANGE
Target $37
BMOC
Outperform
Approval of Noxivent has mitigating factors for Mallinckrodt, says BMO Capital
BMO Capital analyst Gary Nachman kept his Outperform rating and $37 price target on Mallinckrodt (MNK), saying the FDA's approval of Praxair (PX) ANDA for Noxivent, which is a generic form of gas used in the Inomax device for "treating neonates with respiratory failure", has some mitigating factors. The analyst notes that Praxair's device will still have to be approved by the FDA and litigation appeal between the two companies regarding Inomax patents is still ongoing until the first half of next year, with the possibility of a favorable settlement between the two still possible. Moreover, Nachman points to Mallinckrodt's "very strong relationships" with partner hospitals' NICUs, as 25% of its U.S. book of business has been committed for the next couple of years.
10/04/18
STFL
10/04/18
NO CHANGE
Target $30
STFL
Hold
Mallinckrodt selloff today on Praxair ANDA an overreaction, says Stifel
Mallinckrodt (MNK) shares are down sharply this morning following abbreviated new drug application approval of Praxair's (PX) Noxivent, Stifel analyst Annabel Samimy tells investors in a research note. Noxivent's filing as a generic has given investors pause that the gas will be used as a substitute to Mallinckrodt's nitrous oxide in the INOmax System - the leading nitric oxide vasodilator for respiratory failure in term/near-term infants, the analyst says. However, Samimy points out that Noxivent cannot be interchanged with the nitric oxide gas used in the INOmax System, and that thus far, we have not seen a 510(k) approval from the FDA for Praxair's device. Further, the analyst adds that the pending Praxair system will be another branded competitor and not a generic substitute, which she think's today's selloff implies. The analyst also believes consensus estimates have reflected potential competition for well over a year. As such, Samimy thinks today's selloff in Mallinckrodt is overreaction to a "known event". She believes Mallinckrodt is "well-positioned to defend its share." The analyst, nonetheless, keeps a Hold rating on the stock with a $30 price target. The shares in afternoon trading are down 17%, or $5.18, to $25.95.
10/05/18
JEFF
10/05/18
NO CHANGE
Target $35
JEFF
Buy
Mallinckrodt 17% selloff yesterday 'well overdone,' says Jefferies
Jefferies analyst Anthony Petrone views the 17% selloff yesterday in shares of Mallinckrodt (MNK) as "well overdone." The pullback on Praxair's (PX) abbreviated new drug application clearance of Noxivent effectively prices in a $130M revenue shortfall on Mallinckrodt's INOmax in the near term, Petrone tells investors in a research note. Conversely, the analyst expects a more gradual erosion given the ongoing patent appeal process, potential label extension on INOmax, and the need for infrastructure investment on the part of Praxair. He keeps a Buy rating on Mallinckrodt with a $35 price target.
10/08/18
10/08/18
NO CHANGE
Target $24

Market Perform
Wells cuts Mallinckrodt target to $24 after confirming Praxair generic approval
Wells Fargo analyst David Maris says he confirmed this morning with Praxair (PX) that the device associated with generic Inomax has been approved. Praxair would not provide any additional details around the launch timing or pricing plans, Maris tells investors in a research note. The analyst lowered his price target for Mallinckrodt (MNK) shares to $24 from $30 after reducing his estimates to account for the generic taking approximately 20% share over the next several years. He models Mallinckrodt's Inomax going from a 5% grower to a slight decline. Maris admits, however, that there are "strong reasons" to think Inomax has a more defensible position than losing 20% share, such as a loyal installed base and a high service level. Nonetheless, he believes uncertainty around the generic device approval warrant a reduced outlook. The analyst keeps a Market Perform rating on Mallinckrodt. The stock in morning trading is down 5c to $25.83.

TODAY'S FREE FLY STORIES

ATHN

Athenahealth

$132.00

11.63 (9.66%)

12:26
11/12/18
11/12
12:26
11/12/18
12:26
Downgrade
Athenahealth rating change  »

Athenahealth downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USO

United States Oil Fund

$12.90

0.205 (1.61%)

12:20
11/12/18
11/12
12:20
11/12/18
12:20
Options
Vote of confidence in US Oil Fund as shares tick higher »

Vote of confidence in US…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
11/12/18
11/12
12:17
11/12/18
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
11/12/18
11/12
12:16
11/12/18
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DB

Deutsche Bank

$9.80

-0.315 (-3.11%)

12:15
11/12/18
11/12
12:15
11/12/18
12:15
Options
Deutsche Bank put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

C

Citi

$64.55

-1.18 (-1.80%)

12:13
11/12/18
11/12
12:13
11/12/18
12:13
Periodicals
Citi seeks bigger Paris office ahead of Brexit, FT reports »

Citigroup is eyeing a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

  • 14

    Nov

  • 14

    Jan

  • 15

    Apr

  • 13

    Jul

CSLT

Castlight Health

$2.68

-0.01 (-0.37%)

12:11
11/12/18
11/12
12:11
11/12/18
12:11
Conference/Events
Castlight Health management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

  • 27

    Nov

AAPL

Apple

$195.42

-8.89 (-4.35%)

, LITE

Lumentum

$38.36

-17.59 (-31.44%)

12:09
11/12/18
11/12
12:09
11/12/18
12:09
OnTheFly
Fly Intel: Wall Street's top stories at midday »

Stocks opened in negative…

AAPL

Apple

$195.42

-8.89 (-4.35%)

LITE

Lumentum

$38.36

-17.59 (-31.44%)

BABA

Alibaba

$142.11

-2.75 (-1.90%)

PCG

PG&E

$33.72

-6.17 (-15.47%)

EIX

Edison International

$55.03

-5.96 (-9.77%)

SAP

SAP

$101.49

-6.84 (-6.31%)

ATHN

Athenahealth

$132.04

11.67 (9.70%)

APTI

Apptio

$37.60

12.76 (51.37%)

OPK

Opko Health

$3.70

0.595 (19.16%)

BTI

British American Tobacco

$38.56

-3.18 (-7.62%)

GNC

GNC Holdings

$3.36

-0.87 (-20.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 12

    Nov

  • 13

    Nov

  • 14

    Nov

  • 15

    Nov

  • 26

    Nov

PHG

Philips

$37.67

-0.58 (-1.52%)

12:04
11/12/18
11/12
12:04
11/12/18
12:04
Hot Stocks
Philips announces first U.S. patient enrolled in ILLUMENATE BTK IDE study »

Royal Philips announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

MSI

Motorola Solutions

$127.46

-2.24 (-1.73%)

, MSFT

Microsoft

$106.99

-2.55 (-2.33%)

12:02
11/12/18
11/12
12:02
11/12/18
12:02
Hot Stocks
Motorola Solutions selects Microsoft Azure Government cloud for Command »

Motorola Solutions (MSI)…

MSI

Motorola Solutions

$127.46

-2.24 (-1.73%)

MSFT

Microsoft

$106.99

-2.55 (-2.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 12

    Nov

  • 13

    Nov

  • 26

    Nov

  • 28

    Nov

  • 03

    Mar

NAV

Navistar

$29.95

-0.34 (-1.12%)

, CMI

Cummins

$144.61

1.51 (1.06%)

12:01
11/12/18
11/12
12:01
11/12/18
12:01
Periodicals
EPA seeks to 'significantly' cut nitrogen oxide from heavy trucks, Reuters says »

The EPA on Monday intends…

NAV

Navistar

$29.95

-0.34 (-1.12%)

CMI

Cummins

$144.61

1.51 (1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

  • 30

    Nov

EAF

GrafTech

$14.22

-1.86 (-11.57%)

12:00
11/12/18
11/12
12:00
11/12/18
12:00
Hot Stocks
GrafTech falls -11.6% »

GrafTech is down -11.6%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PCG

PG&E

$33.59

-6.3 (-15.79%)

12:00
11/12/18
11/12
12:00
11/12/18
12:00
Hot Stocks
PG&E falls -15.8% »

PG&E is down -15.8%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 12

    Nov

GNC

GNC Holdings

$3.39

-0.845 (-19.98%)

12:00
11/12/18
11/12
12:00
11/12/18
12:00
Hot Stocks
GNC Holdings falls -19.8% »

GNC Holdings is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UVXY

ProShares Trust Ultra VIX Short Term Futures ETF

$54.60

4.55 (9.09%)

12:00
11/12/18
11/12
12:00
11/12/18
12:00
Hot Stocks
ProShares Trust Ultra VIX Short Term Futures ETF rises 9.2% »

ProShares Trust Ultra VIX…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LABD

Daily S&P Biotech Bear 3x Shares

$39.51

4.09 (11.55%)

12:00
11/12/18
11/12
12:00
11/12/18
12:00
Hot Stocks
Daily S&P Biotech Bear 3x Shares rises 11.6% »

Daily S&P Biotech…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BCS

Barclays

$8.76

-0.39 (-4.26%)

12:00
11/12/18
11/12
12:00
11/12/18
12:00
Options
Put buyers in Barclays and implied volatility reaches 52-week highs »

Put buyers in Barclays…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSTI

Best Inc.

$6.10

0.92 (17.76%)

12:00
11/12/18
11/12
12:00
11/12/18
12:00
Hot Stocks
Best Inc. rises 17.0% »

Best Inc. is up 17.0%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 13

    Nov

JPM

JPMorgan

$109.16

-2.08 (-1.87%)

11:58
11/12/18
11/12
11:58
11/12/18
11:58
Periodicals
Bank of France works with JPMorgan to boost gold bullion services, Reuters says »

The Bank of France has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

11:55
11/12/18
11/12
11:55
11/12/18
11:55
Conference/Events
UBS alternative energy analyst to hold an analyst/industry conference call »

Alternative Energy…

11:53
11/12/18
11/12
11:53
11/12/18
11:53
Conference/Events
RBC Capital chemicals analyst to hold a group luncheon »

Chemicals Analyst…

11:51
11/12/18
11/12
11:51
11/12/18
11:51
Conference/Events
UBS alternative energy analyst to hold an analyst/industry conference call »

Alternative Energy…

11:50
11/12/18
11/12
11:50
11/12/18
11:50
Conference/Events
RBC Capital media analyst to hold a group luncheon »

Media Analyst Cahall…

CZR

Caesars

$8.13

-0.39 (-4.58%)

11:50
11/12/18
11/12
11:50
11/12/18
11:50
Options
Caesars option volume heavy as shares test two year lows »

Caesars option volume…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EBAY

eBay

$29.18

-0.45 (-1.52%)

11:45
11/12/18
11/12
11:45
11/12/18
11:45
Options
EBay call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

  • 03

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.